Autonomix Medical, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $5.1M
- Price
- $5.23
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.76%
- Volume
- 109.8K
About
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Quick stats
Shares outstanding971.0K
Computed float502.4K
Float / shares51.7%
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001617867
Websitehttps://autonomix.com
AI Summary
AI-generated1/23
minorbullishoperations update
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
Autonomix Medical announced the successful completion of a Good Laboratory Practice (GLP) preclinical study, marking a significant milestone in its regulatory pathway.
The study evaluated the safety and performance of the Autonomix platform in porcine models, with final histology analyses confirming positive outcomes.
Management views these results as a critical step toward preparing the company's submission to the FDA.